marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-08-2024
AIkido Pharma Financial Ratios 2011-2024 | AIKI
Annual Financial Ratios AIkido Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.7 | -0.8 | -4.7 | -4.5 | -0.7 | 3.3 | -2.1 | -0.6 | -0.1 | -43.7 | -0.0 | - | -1586.9 |
P/S |
8.1 | - | - | - | 329.3 | 202.0 | 5.7 | 4.6 | 105.2 | 133337.2 | 20.6 | - | 6691.5 |
EPS |
-4.4 | -4.9 | -1.5 | -0.4 | -1.7 | 0.9 | -0.6 | 6.8 | -25.0 | -29.4 | -13.6 | -14.1 | 0.1 |
EV (Enterprise Value) |
18.4 M | -13.8 M | -30.7 M | 53.6 M | 3.62 M | 6.79 M | 11.7 M | 9.83 M | 8.28 M | 1.34 B | 19 M | -3.92 M | 5.49 B |
EBITDA per Share |
-4.15 | -2.69 | -1.95 | -0.0223 | -1.07 | -2.86 | -1.88 | -7.1 | -115 | -1.05 | -11.4 K | - | -1.63 |
EV/EBITDA |
-45.5 | -71.6 | -1.1 | -1.0 | -2.8 | -0.6 | -0.1 | -64.1 | 0.2 | - | -1283.2 | ||
PEG |
-0.0 | -0.0 | -0.0 | -0.06 | 0.0 | 0.02 | -0.03 | -0.01 | 0.0 | -0.44 | 0.0 | - | -15.87 |
P/B |
0.3 | 0.2 | 0.3 | 1.9 | 0.3 | 0.5 | 1.7 | 0.8 | 0.4 | 24.9 | 0.0 | 0.7 | 1165.1 |
P/CF |
-0.7 | -1.6 | -5.1 | -10.1 | -0.9 | -2.0 | -2.1 | 60.7 | -0.8 | -140.1 | -0.1 | - | -1258.6 |
ROE % |
-43.24 | -29.97 | -7.06 | -41.65 | -39.72 | 14.28 | -80.52 | -121.78 | -588.17 | -56.98 | -37.19 | - | -73.42 |
ROA % |
-39.75 | -29.00 | -6.99 | -40.46 | -37.08 | 13.03 | -36.85 | -57.43 | -375.82 | -49.92 | -25.72 | - | -61.21 |
ROCE % |
-41.18 | -19.45 | -9.29 | -22.10 | -53.98 | -56.82 | -59.77 | -99.35 | -563.00 | -51.08 | -22.45 | - | -91.28 |
Current Ratio |
12.4 | 30.9 | 96.8 | 31.6 | 1.5 | 2.5 | 1.7 | 2.4 | 0.9 | 3.6 | 2.2 | - | 6.2 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | 103.4 |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | 32850.0 | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | -32850.0 | - | - |
All numbers in USD currency
Quarterly Financial Ratios AIkido Pharma
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.67 | -1.01 | -0.91 | - | -0.66 | -1.79 | -0.71 | - | -1.17 | -1.18 | -0.07 | - | -0.01 | -0.26 | -0.07 | - | -0.06 | -0.07 | -0.91 | - | -1.38 | -0.3 | -0.57 | - | -0.22 | -0.2 | -0.96 | - | 0.08 | -0.38 | -0.19 | - | -0.11 | 9.61 | -0.26 | - | -1.56 | -26.76 | -2.71 | - | -0.18 | -0.69 | -1.66 | - | -6.93 | -1.14 | -5.35 | - | -3.4 | -1.95 | -4.48 | - | -7.13 | -0.4 | -0.1 |
EBITDA per Share |
- | - | -0.46 | - | - | - | -0.72 | - | -0.95 | -0.44 | -0.04 | - | -0.34 | -0.52 | -0.04 | - | -0.03 | -0.05 | -0.26 | - | -0.37 | -0.42 | -0.35 | - | -0.23 | -0.62 | -1.02 | - | -0.16 | -0.09 | -0.2 | - | -0.36 | -0.53 | -0.77 | - | -1.12 | -26.8 | -2.73 | - | -0.1 | -0.54 | -1.67 | - | -6.95 | -1.33 | -1.29 | - | -2.8 | -3.05 | -5.63 | - | -5.74 | -0.39 | -0.45 |
ROE % |
-42.94 | -38.00 | -37.57 | -25.54 | -33.16 | -34.71 | -26.50 | -17.15 | -17.19 | -9.61 | -5.12 | -5.15 | -11.96 | -18.73 | -25.23 | -42.75 | -74.69 | -99.81 | -98.11 | -48.96 | -64.59 | -48.29 | -45.46 | -31.20 | -20.02 | 6.78 | -35.23 | -56.50 | -64.89 | -84.45 | -78.23 | -48.38 | -79.54 | -102.30 | -523.89 | -538.51 | -548.11 | -526.56 | -87.48 | -46.05 | -65.26 | -74.87 | -54.96 | -28.54 | -111.34 | -174.93 | -220.62 | -227.80 | -247.17 | -183.74 | -157.88 | -45.87 | -19.37 | -21.50 | -4.99 |
ROA % |
-38.19 | -34.10 | -34.43 | -18.40 | -25.79 | -27.57 | -20.53 | -16.14 | -16.18 | -8.84 | -4.38 | -5.12 | -11.73 | -18.30 | -24.59 | -41.52 | -71.33 | -94.53 | -92.65 | -45.70 | -59.97 | -44.43 | -41.73 | -28.49 | -23.37 | -3.99 | -21.71 | -25.86 | -29.81 | -38.88 | -36.58 | -22.82 | -42.72 | -58.67 | -334.60 | -344.09 | -352.50 | -341.01 | -65.57 | -40.35 | -53.63 | -58.51 | -40.75 | -19.73 | -34.61 | -36.20 | -43.56 | -40.93 | -57.08 | -58.35 | -67.77 | -38.24 | -16.15 | -17.93 | -4.16 |
ROCE % |
- | - | - | - | -6.23 | -12.46 | -15.09 | -12.86 | -14.58 | -10.08 | -10.13 | -6.62 | -9.88 | -11.42 | -14.80 | -17.42 | -25.98 | -31.29 | -33.66 | -23.77 | -39.89 | -47.45 | -49.45 | -39.59 | -62.95 | -70.18 | -78.67 | -65.88 | -78.40 | -67.56 | -61.13 | -54.36 | -76.75 | -86.62 | -368.44 | -363.74 | -373.37 | -360.62 | -87.93 | -46.20 | -65.49 | -75.15 | -55.48 | -23.14 | -97.29 | -152.16 | -228.48 | -276.95 | -293.67 | -236.25 | -179.66 | -62.00 | -16.73 | -21.70 | -23.58 |
Current Ratio |
8.4 | 7.3 | 11.5 | 12.4 | 13.0 | 11.4 | - | 30.9 | 32.5 | 106.5 | 131.8 | 96.8 | 58.0 | 99.0 | 187.7 | 34.8 | 34.8 | 34.8 | 34.8 | 15.0 | 15.0 | 15.0 | 15.0 | 11.5 | 11.5 | 11.5 | 11.5 | 1.8 | 1.8 | 1.8 | 1.8 | 1.9 | 1.9 | 1.9 | 1.9 | 2.8 | 4.8 | 10.6 | 2.8 | 37.4 | 37.4 | 37.4 | 37.4 | 45.0 | 43.1 | 123.2 | 97.7 | 1.2 | 1.2 | 1.2 | 1.2 | 3.0 | 6.0 | 6.0 | 6.0 |
DSO |
- | - | - | - | 5.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 281.7 | 10.0 | - | 572.0 | - | 31.8 | - | 131.5 | 127.2 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | 5.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 281.7 | 10.0 | - | 572.0 | - | 31.8 | - | 131.5 | 127.2 | - |
Cash Conversion Cycle |
- | - | - | - | 5.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 281.7 | 10.0 | - | 572.0 | - | 31.8 | - | 131.5 | 127.2 | - |
All numbers in USD currency